Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment.
Diem S, Fässler M, Bomze D, Ali OH, Berner F, Niederer R, Hillmann D, Mangana J, Levesque MP, Dummer R, Risch L, Recher M, Risch M, Flatz L.
Diem S, et al. Among authors: risch m, risch l.
J Immunother. 2019 Apr;42(3):89-93. doi: 10.1097/CJI.0000000000000255.
J Immunother. 2019.
PMID: 30768543
Free article.